Loading clinical trials...

Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316) | Clinical Trials | Clareo Health

COMPLETEDPHASE3

Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)

A Double-Blind, Randomized Multicenter, 3-Period, Crossover Study to Evaluate the Effects of a Single Dose of Montelukast Compared With Placebo and Salmeterol on Exercise-Induced Bronchoconstriction

NCT00245570•Organon and Co

View on ClinicalTrials.gov

Summary

To determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in patients who have a history of worsening asthma after exercise.

Eligibility

Age

15 - 45 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Physician-diagnosed exercise-induced bronchospasm

Exclusion Criteria

•Patient is, other than asthma, not in good, stable health. The Primary Investigator will evaluate whether there are other reasons why the patient may not participate.

Key Dates

Start Date

December 1, 2005

Primary Completion Date

September 1, 2006

Completion Date

September 1, 2006

Last Updated

February 2, 2022

Enrollment

ACTUAL participants

Conditions

Asthma, Exercise-Induced

Interventions

Comparator: Montelukast

DRUG

Comparator: Salmeterol

DRUG

Comparator: Placebo (montelukast)

DRUG

Comparator: Placebo (salmeterol)

DRUG

Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)

NCT00092131

Asthma, Exercise-Induced

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 2, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions